285 related articles for article (PubMed ID: 21596025)
1. Allosteric modulators of the α4β2 subtype of neuronal nicotinic acetylcholine receptors.
Pandya A; Yakel JL
Biochem Pharmacol; 2011 Oct; 82(8):952-8. PubMed ID: 21596025
[TBL] [Abstract][Full Text] [Related]
2. Effects of neuronal nicotinic acetylcholine receptor allosteric modulators in animal behavior studies.
Pandya AA; Yakel JL
Biochem Pharmacol; 2013 Oct; 86(8):1054-62. PubMed ID: 23732296
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of nicotinic acetylcholine receptors.
Chatzidaki A; Millar NS
Biochem Pharmacol; 2015 Oct; 97(4):408-417. PubMed ID: 26231943
[TBL] [Abstract][Full Text] [Related]
4. Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators.
Wilkerson JL; Deba F; Crowley ML; Hamouda AK; McMahon LR
Neuropharmacology; 2020 May; 168():108008. PubMed ID: 32113032
[TBL] [Abstract][Full Text] [Related]
5. α4β2* neuronal nicotinic receptor ligands (agonist, partial agonist and positive allosteric modulators) as therapeutic prospects for pain.
Nirogi R; Goura V; Abraham R; Jayarajan P
Eur J Pharmacol; 2013 Jul; 712(1-3):22-9. PubMed ID: 23660369
[TBL] [Abstract][Full Text] [Related]
6. Targeting α4β2 nicotinic acetylcholine receptors in central nervous system disorders: perspectives on positive allosteric modulation as a therapeutic approach.
Grupe M; Grunnet M; Bastlund JF; Jensen AA
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):187-200. PubMed ID: 25441336
[TBL] [Abstract][Full Text] [Related]
7. Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
Gill-Thind JK; Dhankher P; D'Oyley JM; Sheppard TD; Millar NS
J Biol Chem; 2015 Feb; 290(6):3552-62. PubMed ID: 25516597
[TBL] [Abstract][Full Text] [Related]
8. Desformylflustrabromine: A Novel Positive Allosteric Modulator for beta2 Subunit Containing Nicotinic Receptor Sub-Types.
Pandya AA
Curr Pharm Des; 2016; 22(14):2057-63. PubMed ID: 26818864
[TBL] [Abstract][Full Text] [Related]
9. The subtype-selective nicotinic acetylcholine receptor positive allosteric potentiator 2087101 differentially facilitates neurotransmission in the brain.
de Filippi G; Mogg AJ; Phillips KG; Zwart R; Sher E; Chen Y
Eur J Pharmacol; 2010 Sep; 643(2-3):218-24. PubMed ID: 20624387
[TBL] [Abstract][Full Text] [Related]
10. Positive and negative modulation of nicotinic receptors.
Arias HR
Adv Protein Chem Struct Biol; 2010; 80():153-203. PubMed ID: 21109220
[TBL] [Abstract][Full Text] [Related]
11. Discovery and development of α7 nicotinic acetylcholine receptor modulators.
Mazurov AA; Speake JD; Yohannes D
J Med Chem; 2011 Dec; 54(23):7943-61. PubMed ID: 21919481
[No Abstract] [Full Text] [Related]
12. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
[TBL] [Abstract][Full Text] [Related]
13. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
[TBL] [Abstract][Full Text] [Related]
14. Two distinct allosteric binding sites at α4β2 nicotinic acetylcholine receptors revealed by NS206 and NS9283 give unique insights to binding activity-associated linkage at Cys-loop receptors.
Olsen JA; Kastrup JS; Peters D; Gajhede M; Balle T; Ahring PK
J Biol Chem; 2013 Dec; 288(50):35997-6006. PubMed ID: 24169695
[TBL] [Abstract][Full Text] [Related]
15. Contrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptors.
Gill JK; Chatzidaki A; Ursu D; Sher E; Millar NS
PLoS One; 2013; 8(1):e55047. PubMed ID: 23383051
[TBL] [Abstract][Full Text] [Related]
16. Designing selective modulators for the nicotinic receptor subtypes: challenges and opportunities.
Manetti D; Bellucci C; Chiaramonte N; Dei S; Teodori E; Romanelli MN
Future Med Chem; 2018 Feb; 10(4):433-459. PubMed ID: 29451400
[TBL] [Abstract][Full Text] [Related]
17. Identification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptors.
Pavlovicz RE; Henderson BJ; Bonnell AB; Boyd RT; McKay DB; Li C
PLoS One; 2011; 6(9):e24949. PubMed ID: 21949802
[TBL] [Abstract][Full Text] [Related]
18. Role of the Cys Loop and Transmembrane Domain in the Allosteric Modulation of α4β2 Nicotinic Acetylcholine Receptors.
Alcaino C; Musgaard M; Minguez T; Mazzaferro S; Faundez M; Iturriaga-Vasquez P; Biggin PC; Bermudez I
J Biol Chem; 2017 Jan; 292(2):551-562. PubMed ID: 27864368
[TBL] [Abstract][Full Text] [Related]
19. Molecular modelling studies on ɑ7 nicotinic receptor allosteric modulators yields novel filter-based virtual screening protocol.
Al Rawashdah S; Hamrouni A; Sadek B; Amer R; Metwaly M; Atatreh N; Ghattas MA
J Mol Graph Model; 2019 Nov; 92():44-54. PubMed ID: 31306865
[TBL] [Abstract][Full Text] [Related]
20. Allosteric modulators of α4β2 nicotinic acetylcholine receptors: a new direction for antidepressant drug discovery.
Mantione E; Micheloni S; Alcaino C; New K; Mazzaferro S; Bermudez I
Future Med Chem; 2012 Nov; 4(17):2217-30. PubMed ID: 23190109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
